Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Buy
2,309
+157
+7% +$18.4K 0.07% 123
2026
Q1
$259K Buy
2,152
+132
+7% +$15.2K 0.08% 126
2025
Q4
$213K Buy
+2,020
New +$190K 0.06% 135
2025
Q1
Sell
-2,704
Closed -$269K 124
2024
Q4
$269K Buy
2,704
+455
+20% +$46.9K 0.11% 106
2024
Q3
$255K Sell
2,249
-389
-15% -$46.2K 0.1% 105
2024
Q2
$327K Buy
2,638
+204
+8% +$26.3K 0.15% 84
2024
Q1
$321K Sell
2,434
-328
-12% -$40.4K 0.15% 87
2023
Q4
$301K Sell
2,762
-2,308
-46% -$240K 0.15% 92
2023
Q3
$522K Sell
5,070
-82
-2% -$8.84K 0.3% 56
2023
Q2
$594K Buy
5,152
+1,986
+63% +$225K 0.34% 53
2023
Q1
$337K Buy
3,166
+6
+0.2% +$648 0.24% 66
2022
Q4
$351K Buy
3,160
+585
+23% +$59.8K 0.28% 53
2022
Q3
$222K Buy
2,575
+115
+5% +$10.3K 0.2% 65
2022
Q2
$224K Hold
2,460
0.2% 65
2022
Q1
$202K Hold
2,460
0.17% 83
2021
Q4
$189K Buy
+2,460
New +$196K 0.16% 82

Other funds holding MRK

Sandy Cove Advisors's MRK Position: Q2 2026 in Review

Sandy Cove Advisors increased its Merck (MRK) stake by 7.3% in Q2 2026, buying an estimated $18.4K and bringing the position to 2,309 shares worth $297K. The position accounts for 0.07% of the portfolio, ranked #123.

Sandy Cove Advisors first reported a position in MRK in Q4 2021 and has held it in 16 quarters since. The position peaked at $594K in Q2 2023. 1,553 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sandy Cove Advisors held 2,309 shares of Merck worth $297K as of Q2 2026.
  • Sandy Cove Advisors bought 157 Merck shares in Q2 2026, an estimated $18.4K.
  • Merck made up 0.07% of Sandy Cove Advisors's portfolio in Q2 2026, its #123 holding.
  • Sandy Cove Advisors first reported a position in Merck in Q4 2021 and has held it in 16 quarters since.
  • Sandy Cove Advisors's Merck position peaked at $594K in Q2 2023.
  • 1,553 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.